3-179218304-A-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Moderate
The NM_006218.4(PIK3CA):c.1634A>G(p.Glu545Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E545K) has been classified as Pathogenic.
Frequency
Consequence
NM_006218.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PIK3CA related overgrowth syndrome Pathogenic:1
A PIK3CA c.1634A>G (p.Glu545Gly) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals with PIK3CA-Related Overgrowth Spectrum (PROS) disorders (Luks VL et al., PMID: 25681199; Serio VB et al., PMID: 37662840; Vahidnezhad H et al., PMID: 27037860). The PIK3CA c.1634A>G (p.Glu545Gly) variant has been reported numerous times in the Catalogue of Somatic Mutations in Cancer (COSMIC) (Genomic Mutation ID: COSV55873220). This variant is absent from the general population (gnomAD v4.0.0), indicating it is not a common variant. Computational predictors indicate that this variant is damaging, evidence that correlates with impact to PIK3CA function. The PIK3CA gene is defined by the ClinGen Brain Malformations Variant Curation Expert Panel as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (Lai et al., PMID: 35997716). Other variants in the same codon, c.1634A>C (p.Glu545Ala), c.1633G>A (p.Glu545Lys), and c.1635G>T (p.Glu545Asp), have been reported and are considered pathogenic/likely pathogenic (ClinVar Variation IDs: 13659, 13655, and 217293). Based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, the PIK3CA c.1634A>G (p.Glu545Gly) variant is classified as pathogenic. -
Carcinoma of colon Pathogenic:1
- -
Epidermal nevus Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at